News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Anesthetics Developer Zars, Inc. Caps A $5 Million Series B Round


10/19/2005 5:10:25 PM

Zars, a pharmaceutical company that develops and markets products for pain, anxiety disorders, and nausea, said it has raised $5 million in its Series B round of financing.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES